secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001641172-25-010873
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Cyclacel Pharmaceuticals Q1 2025: Deconsolidation Gain, FITTERS Exchange, Focus on Plogosertib
--------------------------------------------------------------------------------

- Cyclacel reported Q1 2025 net loss of $0.1 million, compared to $2.9 million in Q1 2024.
- Deconsolidation of UK subsidiary Cyclacel Limited resulted in a $5.0 million gain on deconsolidation.
- Company repurchased plogosertib assets from Cyclacel Limited for approximately $0.3 million.
- Entered into an Exchange Agreement with FITTERS Diversified Berhad to acquire Fitters Sdn. Bhd. for 19.99% of common stock.
- Cash and cash equivalents totaled $3.5 million as of March 31, 2025, expected to fund into Q2 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225010873/0001641172-25-010873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225010873/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-010873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer